Changes in Pulmonary Circulation in Experimental Model of Pulmonary Thromboembolism after Carvedilol Treatment

被引：0
作者：
I. Evlakhov
I. Z. Poyassov
V. I. Ovsyannikov
机构：
[1] Laboratory of Physiology of Visceral System,
[2] Institute of Experimental Medicine,undefined
来源：
Bulletin of Experimental Biology and Medicine | 2019年 / 167卷
关键词：
carvedilol; isolated lungs; pulmonary thromboembolism; capillary filtration coefficient; pulmonary veins;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In experiments on isolated perfused rabbit lungs, we studied changes in the pulmonary microcirculation in response to carvedilol injection and after modelling pulmonary thromboembolism under conditions of α1- and β1,2-adrenoceptor blockade with this drug. Carvedilol had mainly vasodilator effects on the pulmonary arterial vessels; the pulmonary venous resistance increased and the capillary filtration coefficient remained unchanged under these conditions. In case of pulmonary thromboembolism against the background of carvedilol treatment, the increase in precapillary resistance and the capillary filtration coefficient was more pronounced that in the control, but the postcapillary resistance increased to a lesser extent. The increase in the capillary filtration coefficient is a result of elevated precapillary resistance and enhanced endothelial permeability.
引用
收藏
页码：432 / 435
页数：3
相关论文
共 74 条
  • [1] Evlakhov VI(2019)Pulmonary Microcirculation in Experimental Model of Pulmonary Thromboembolism under Conditions of α-Adrenoceptor Blockade Bull. Exp. Biol. Med. 166 313-316
  • [2] Poyassov IZ(2010)Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats Am. J. Respir. Crit. Care Med. 182 652-660
  • [3] Ovsyannikov VI(2016)α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury Oncotarget. 7 55 990-56 001
  • [4] Bogaard HJ(2013)Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension Physiol. Genomics. 45 449-461
  • [5] Natarajan R(2006)Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension J. Cardiovasc. Pharmacol. 47 250-255
  • [6] Mizuno S(2007)Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins Br. J. Pharmacol. 151 186-194
  • [7] Abbate A(2018)Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension Am. J. Physiol. Heart Circ. Physiol. 314 H542-H551
  • [8] Chang PJ(2012)Alpha2C-adrenoceptors play a prominent role in sympathetic constriction of porcine pulmonary arteries Naunyn. Schmiedebergs Arch. Pharmacol. 385 595-603
  • [9] Chau VQ(2015)Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension J. Mol. Med. (Berl). 93 663-674
  • [10] Hoke NN(2015)Regulation of β-adrenergic receptor trafficking and lung microvascular endothelial cell permeability by Rab5 GTPase Int. J. Biol. Sci. 11 868-878
12345678